Kusano Chika, Gotoda Takuji, Khor Christopher J, Katai Hitoshi, Kato Hoichi, Taniguchi Hirokazu, Shimoda Tadakazu
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
J Gastroenterol Hepatol. 2008 Nov;23(11):1662-5. doi: 10.1111/j.1440-1746.2008.05572.x.
A dramatic increase in incidence of adenocarcinoma of the esophagogastric junction (EGJ) over the past two decades has been reported in the West. However, epidemiological data from Asian countries have not shown a similar trend. The aim of this study was to determine the incidence of adenocarcinoma of the EGJ in a cohort of consecutive patients operated on for gastric adenocarcinoma at a major cancer referral center in Japan.
We reviewed pathological reports of all patients who underwent surgery for advanced gastric adenocarcinoma between 1962 and 2005 at the National Cancer Centre Hospital in Tokyo. Adenocarcinoma of the EGJ was defined from images recorded for each patient, in accordance with the classification of Siewert and Stein. The proportion of adenocarcinoma at the EGJ among operated gastric adenocarcinoma patients was compiled at five-year intervals and serial comparison made.
A total of 6953 patients with advanced gastric adenocarcinoma were operated on; adenocarcinoma of EGJ was found in 520 patients. The overall proportion of adenocarcinoma of the EGJ increased from 2.3% (1962-1965) to 10.0% (2001-2005). The proportion of Siewert Type II rose from 28.5% (1962-1965) to 57.3% (2001-2005), while that of Type I remained at around 1%.
An increasing trend of adenocarcinoma of EGJ is observed in this study of patients operated on for gastric adenocarcinoma from 1962 to 2005 in a large tertiary referral center in Japan.
据报道,在过去二十年中,西方食管胃交界部(EGJ)腺癌的发病率急剧上升。然而,亚洲国家的流行病学数据并未显示出类似趋势。本研究的目的是确定在日本一家主要癌症转诊中心接受胃腺癌手术的连续患者队列中EGJ腺癌的发病率。
我们回顾了1962年至2005年期间在东京国立癌症中心医院接受晚期胃腺癌手术的所有患者的病理报告。根据Siewert和Stein的分类,从为每位患者记录的图像中定义EGJ腺癌。按五年间隔汇总接受手术的胃腺癌患者中EGJ腺癌的比例,并进行系列比较。
共有6953例晚期胃腺癌患者接受了手术;其中520例患者被发现患有EGJ腺癌。EGJ腺癌的总体比例从2.3%(1962 - 1965年)增至10.0%(2001 - 2005年)。Siewert II型的比例从28.5%(1962 - 1965年)升至57.3%(2001 - 2005年),而I型的比例则保持在1%左右。
在日本一家大型三级转诊中心对1962年至2005年接受胃腺癌手术的患者进行的这项研究中,观察到EGJ腺癌呈上升趋势。